| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function
|
Hande, Liv Nesse
|
|
|
13 |
5 |
p. 762-770
|
article
|
| 2 |
Editorial Board
|
|
|
|
13 |
5 |
p. A1-A4
|
article
|
| 3 |
From the editor: Considering less carbohydrate
|
Guyton, John R.
|
|
|
13 |
5 |
p. 673-674
|
article
|
| 4 |
Impact of improved low-density lipoprotein cholesterol assessment on guideline classification in the modern treatment era—Results from a racially diverse Brazilian cross-sectional study
|
Pallazola, Vincent A.
|
|
|
13 |
5 |
p. 804-811.e2
|
article
|
| 5 |
Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial
|
Khan, Tina Z.
|
|
|
13 |
5 |
p. 788-796
|
article
|
| 6 |
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels
|
Pavanello, Chiara
|
|
|
13 |
5 |
p. 778-787.e6
|
article
|
| 7 |
JCL roundtable: Pediatric lipidology
|
Peterson, Amy L.
|
|
|
13 |
5 |
p. 676-688
|
article
|
| 8 |
Mortality reduction with PCSK9 inhibition: A case of cautious optimism
|
Dixon, Dave L.
|
|
|
13 |
5 |
p. 712-713
|
article
|
| 9 |
News from the NLA
|
|
|
|
13 |
5 |
p. 675
|
article
|
| 10 |
PCSK9 inhibition, atherosclerotic cardiovascular disease, and health economics: Challenges at the crossroads
|
Annemans, Lieven
|
|
|
13 |
5 |
p. 714-720
|
article
|
| 11 |
PCSK9 inhibition in patients with heart transplantation: A case series
|
Sandesara, Pratik B.
|
|
|
13 |
5 |
p. 721-724
|
article
|
| 12 |
Pseudohypertriglyceridemia—Raising clinical awareness
|
Backes, James M.
|
|
|
13 |
5 |
p. 855-856
|
article
|
| 13 |
RAB18 modulates autophagy in human stellate cells
|
BasuRay, Soumik
|
|
|
13 |
5 |
p. 832-838
|
article
|
| 14 |
Race–ethnic differences in the associations of maternal lipid trait genetic risk scores with longitudinal fetal growth
|
Ouidir, Marion
|
|
|
13 |
5 |
p. 821-831
|
article
|
| 15 |
Rapid improvement in carotid adventitial angiogenesis and plaque neovascularization after rosuvastatin therapy in statin treatment–naïve subjects
|
Du, Ruixue
|
|
|
13 |
5 |
p. 847-853
|
article
|
| 16 |
Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force
|
Kirkpatrick, Carol F.
|
|
|
13 |
5 |
p. 689-711.e1
|
article
|
| 17 |
Screening for hyperglycerolemia by triglyceride assay in urine
|
Fernández-Pardo, Jacinto
|
|
|
13 |
5 |
p. 854-855
|
article
|
| 18 |
Serum concentration of full-length- and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease
|
Nagao, Manabu
|
|
|
13 |
5 |
p. 839-846
|
article
|
| 19 |
Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans
|
Soohoo, Melissa
|
|
|
13 |
5 |
p. 744-753.e15
|
article
|
| 20 |
Table of Contents
|
|
|
|
13 |
5 |
p. A5-A7
|
article
|
| 21 |
The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis
|
Lai, Yong Chang
|
|
|
13 |
5 |
p. 812-820
|
article
|
| 22 |
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy
|
Case, Brian C.
|
|
|
13 |
5 |
p. 754-761
|
article
|
| 23 |
The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice
|
Bradley, Corey K.
|
|
|
13 |
5 |
p. 725-734
|
article
|
| 24 |
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs
|
Virani, Salim S.
|
|
|
13 |
5 |
p. 797-803.e1
|
article
|
| 25 |
Translating plasma eicosapentaenoic acid concentrations into erythrocyte percentages of eicosapentaenoic acid plus docosahexaenoic acid during treatment with icosapent ethyl
|
Harris, William S.
|
|
|
13 |
5 |
p. 771-777
|
article
|
| 26 |
Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies
|
Raal, Frederick J.
|
|
|
13 |
5 |
p. 735-743
|
article
|
Journal description